{"transactions":[{"id":797083,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:08:04.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001926476-26-000002","document":"wk-form4_1777594081.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000192647626000002/wk-form4_1777594081.xml","form_type":"4"}},{"id":1156316,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:16:02.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000048","document":"wk-form4_1746652555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000048/wk-form4_1746652555.xml","form_type":"4"}},{"id":1530692,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:33:08.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003751","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003751/primarydocument.xml","form_type":"4"}},{"id":1698092,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-29T23:25:20.000Z","date":"2023-12-29","kind":"exercise","planned":false,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":114000,"derivative":{"exercise_price":7,"expiration_date":"2032-10-03","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001562180-23-008590","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218023008590/primarydocument.xml","form_type":"4"}},{"id":1698091,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-29T23:25:20.000Z","date":"2023-12-29","kind":"sale","planned":false,"acquired":false,"shares":11000,"price":41.7875,"value":459662.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.74 - $41.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":2535,"source":{"system":"sec-edgar","filing":"0001562180-23-008590","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218023008590/primarydocument.xml","form_type":"4"}},{"id":1698090,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-29T23:25:20.000Z","date":"2023-12-29","kind":"exercise","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13535,"source":{"system":"sec-edgar","filing":"0001562180-23-008590","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218023008590/primarydocument.xml","form_type":"4"}},{"id":1904637,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-04T21:51:51.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":52906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 2, 2024 or (b) the date of the 2024  Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":52906,"derivative":{"exercise_price":13.2,"expiration_date":"2033-05-02","underlying":"Common Shares","underlying_shares":52906},"source":{"system":"sec-edgar","filing":"0001562180-23-003943","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218023003943/primarydocument.xml","form_type":"4"}},{"id":2142536,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:41:33.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":125000,"derivative":{"exercise_price":7,"expiration_date":"2032-10-04","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001562180-22-007084","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007084/primarydocument.xml","form_type":"4"}},{"id":2142535,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:41:33.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":2535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Effective as of a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd. (\"RemainCo\") to holders of its common shares (the \"Distribution\") pursuant to the Separation and Distribution Agreement (the \"Separation Agreement\"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. (\"Pfizer\"), each outstanding restricted share unit of RemainCo was adjusted so that such restricted share unit became a restricted share unit in respect of common shares (\"Common Shares\") of the Issuer (each, an \"Issuer RSU\") and a restricted share unit in respect of RemainCo common shares. (Cont'd in FN2)"},{"field":"shares","element":"transactionShares","label":"F2","text":"(Cont'd from FN1) As a result, the Reporting Person acquired restricted share units in respect of Common Shares in an amount determined in accordance with the Separation Agreement. At the effective time of the merger of a wholly owned subsidiary of Pfizer (\"Merger Sub\") with and into RemainCo pursuant to the Agreement and Plan of Merger, dated as of May 9, 2022, by and among RemainCo, Pfizer and Merger Sub, the Issuer RSUs accelerated and vested in full and will subsequently be settled in Common Shares."}],"balance_after":2535,"source":{"system":"sec-edgar","filing":"0001562180-22-007084","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007084/primarydocument.xml","form_type":"4"}},{"id":2147413,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit Award","published_at":"2022-10-03T20:25:10.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":5070,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Under the Agreement and Plan of Merger, dated as of May 9, 2022 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Pfizer\") and a wholly owned subsidiary of Pfizer (\"Merger Sub\"), following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on October 3, 2022 Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the distribution (\"Distribution\") by the Issuer to holders of its common shares of all the outstanding common shares of Biohaven Ltd. (\"SpinCo\"), each outstanding restricted share unit of the Issuer was adjusted such that such restricted share unit became a restricted share unit in respect of common shares of SpinCo and a restricted share unit in respect of Common Shares (each such restricted share unit, a \"Post-Spin Issuer RSU\"). At the effective time of the Merger, each outstanding Post-Spin Issuer RSU was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the number of Common Shares subject to such Post-Spin Issuer RSU, with any performance conditions applicable to such Post-Spin Issuer RSU deemed achieved at 100%, and (ii) the Merger Consideration, less any withholding taxes."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":5070},"source":{"system":"sec-edgar","filing":"0001562180-22-006954","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218022006954/primarydocument.xml","form_type":"4"}},{"id":2273555,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit Award","published_at":"2022-05-12T20:57:58.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":5070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents the contingent right to receive one common share of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted 5,070 restricted share units on May 11, 2022, vesting in four equal installments on May 11, 2022, 2023, 2024 and 2025 subject to the reporting person's continued service with the issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":5070,"derivative":{"underlying":"Common Shares","underlying_shares":5070},"source":{"system":"sec-edgar","filing":"0001562180-22-004013","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218022004013/primarydocument.xml","form_type":"4"}}]}